校正:自组装的纳米粒子疫苗产生了有效的中和抗体反应,对抗EBV感染
Ping Li1,2, Ziyi Jiang1, Jingjing Shi1
1Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Frontiers in immunology
|February 19, 2025
概括
这项研究纠正了先前发表的一篇文章DOI. 校正确保准确的引用和参考,用于该领域的未来研究.
科学领域:
- 免疫学 免疫学 免疫学
- 科学出版 科研出版
背景情况:
- 准确的引用对于科学完整性至关重要.
- 确保正确的数字物体标识符 (DOI) 对于研究可追溯性至关重要.
研究的目的:
- 为以前发表的文章提供纠正DOI.
- 保持科学记录的准确性和可靠性.
主要方法:
- 发布了一份纠正通知.
- 正确的DOI被确定并公布.
主要成果:
- 文章的DOI已经被纠正为10.3389/fimmu.2024.1530364.
- 这样可以确保正确的链接和对研究的访问.
结论:
- 校正符合科学传播的标准.
- 研究人员现在可以准确地引用和访问修正的文章.
相关概念视频
00:42Cross-reactivity
Overview
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...